The University of Hong Kong: Kidney Diseases trials
The registry lists 14 Kidney Diseases studies with The University of Hong Kong as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 2 3Phase 3 2Phase 4 4No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Assessment of Kidney Function by Electrical Impedance Tomography (EIT)RecruitingNCT06898294
- SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney DiseaseRecruitingNCT06155604Phase 2
- The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable DiseasesRecruitingNCT05248412
- Cohort Study on Patient Outcomes, Effectiveness and Cost-effectiveness of Intervention Programmes for DM/HT PatientsCompletedNCT04302974
- Renoprotective Effects of Telbivudine in Chronic Hepatitis BCompletedNCT03778567Phase 4
- Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney DiseaseStatus unknownNCT03535935Phase 2/3
- Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic NephropathyStatus unknownNCT02488252Phase 2/3
- Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney DiseaseCompletedNCT01150201Phase 4
- Aliskiren for Proteinuric IgAN Despite Angiotensin BlockadeCompletedNCT00922311Phase 4
- Mycophenolate Mofetil for IgA NephropathyCompletedNCT00863252Phase 4
- Oral Paricalcitol in Stage 3 - 5 Chronic Kidney DiseaseCompletedNCT00796679Not applicable
- Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease PatientsCompletedNCT00745914Not applicable
- Parathyroidectomy in Endstage Renal DiseaseCompletedNCT00745719Not applicable
- Sevelamer Hydrochloride in Peritoneal Dialysis PatientsCompletedNCT00745589Not applicable